Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Erratum to: Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients.

Den Heijer CDJ, Hoebe CJPA, Driessen JHM, Wolffs P, Van Den Broek IVF, Hoenderboom BM, Williams R, De Vries F, Dukers-Muijrers NHTM.

Clin Infect Dis. 2019 Sep 19. pii: ciz897. doi: 10.1093/cid/ciz897. [Epub ahead of print] No abstract available.

PMID:
31535123
2.

A protocol integrating remote patient monitoring patient reported outcomes and cardiovascular biomarkers.

Shufelt C, Dzubur E, Joung S, Fuller G, Mouapi KN, Van Den Broek I, Lopez M, Dhawan S, Arnold CW, Speier W, Mastali M, Fu Q, Van Eyk JE, Spiegel B, Merz CNB.

NPJ Digit Med. 2019 Sep 3;2:84. doi: 10.1038/s41746-019-0145-6. eCollection 2019.

3.

Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients.

den Heijer CDJ, Hoebe CJPA, Driessen JHM, Wolffs P, van den Broek IVF, Hoenderboom BM, Williams R, de Vries F, Dukers-Muijrers NHTM.

Clin Infect Dis. 2019 Oct 15;69(9):1517-1525. doi: 10.1093/cid/ciz429.

4.

Evaluation and enumeration of online test providers for sexually transmitted infections, specifically chlamydia, in the Netherlands.

den Daas C, Sukel B, Bos H, van den Broek I 1st.

Sex Transm Infect. 2019 Aug;95(5):380-385. doi: 10.1136/sextrans-2018-053771. Epub 2019 Jan 22.

5.

Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial.

Hoenderboom BM, van Benthem BHB, van Bergen JEAM, Dukers-Muijrers NHTM, Götz HM, Hoebe CJPA, Hogewoning AA, Land JA, van der Sande MAB, Morré SA, van den Broek IVF.

Sex Transm Infect. 2019 Jun;95(4):300-306. doi: 10.1136/sextrans-2018-053778. Epub 2019 Jan 3.

6.

Proteins and Clinical Mass Spectrometry: A Fairy Tale?

van den Broek I.

Clin Chem. 2019 Feb;65(2):220-221. doi: 10.1373/clinchem.2018.298869. Epub 2018 Dec 6. No abstract available.

PMID:
30523200
7.

National prevalence estimates of chlamydia and gonorrhoea in the Netherlands.

Heijne JCM, van den Broek IVF, Bruisten SM, van Bergen JEA, de Graaf H, van Benthem BHB.

Sex Transm Infect. 2019 Feb;95(1):53-59. doi: 10.1136/sextrans-2017-053478. Epub 2018 Jun 20.

PMID:
29925670
8.

A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands.

Nanhoe AC, Visser M, Omlo JJ, Watzeels AJCM, van den Broek IV, Götz HM.

BMC Infect Dis. 2018 May 29;18(1):243. doi: 10.1186/s12879-018-3139-0.

9.

STIs in sex partners notified for chlamydia exposure: implications for expedited partner therapy.

van Aar F, van Benthem BHB, van den Broek IVF, Götz HM.

Sex Transm Infect. 2018 Dec;94(8):619-621. doi: 10.1136/sextrans-2017-053364. Epub 2018 Jan 11.

PMID:
29326177
10.

Partner notification and partner treatment for chlamydia: attitude and practice of general practitioners in the Netherlands; a landscape analysis.

van den Broek IVF, Donker GA, Hek K, van Bergen JEAM, van Benthem BHB, Götz HM.

BMC Fam Pract. 2017 Dec 20;18(1):103. doi: 10.1186/s12875-017-0676-3.

11.

Chlamydia trachomatis antibody detection in home-collected blood samples for use in epidemiological studies.

Hoenderboom BM, van Ess EF, van den Broek IVF, van Loo IHM, Hoebe CJPA, Ouburg S, Morré SA.

J Microbiol Methods. 2018 Jan;144:164-167. doi: 10.1016/j.mimet.2017.11.022. Epub 2017 Nov 28.

12.

Highly Reproducible Automated Proteomics Sample Preparation Workflow for Quantitative Mass Spectrometry.

Fu Q, Kowalski MP, Mastali M, Parker SJ, Sobhani K, van den Broek I, Hunter CL, Van Eyk JE.

J Proteome Res. 2018 Jan 5;17(1):420-428. doi: 10.1021/acs.jproteome.7b00623. Epub 2017 Nov 10.

13.

Advances in quantifying apolipoproteins using LC-MS/MS technology: implications for the clinic.

van den Broek I, Sobhani K, Van Eyk JE.

Expert Rev Proteomics. 2017 Oct;14(10):869-880. doi: 10.1080/14789450.2017.1374859. Epub 2017 Sep 8. Review.

PMID:
28870113
14.

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

Hoenderboom BM, van Oeffelen AA, van Benthem BH, van Bergen JE, Dukers-Muijrers NH, Götz HM, Hoebe CJ, Hogewoning AA, van der Klis FR, van Baarle D, Land JA, van der Sande MA, van Veen MG, de Vries F, Morré SA, van den Broek IV.

BMC Infect Dis. 2017 Apr 11;17(1):264. doi: 10.1186/s12879-017-2376-y.

15.

Does the Use of a Decision Aid Improve Decision Making in Prosthetic Heart Valve Selection? A Multicenter Randomized Trial.

Korteland NM, Ahmed Y, Koolbergen DR, Brouwer M, de Heer F, Kluin J, Bruggemans EF, Klautz RJ, Stiggelbout AM, Bucx JJ, Roos-Hesselink JW, Polak P, Markou T, van den Broek I, Ligthart R, Bogers AJ, Takkenberg JJ.

Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). pii: e003178. doi: 10.1161/CIRCOUTCOMES.116.003178. Epub 2017 Feb 22.

PMID:
28228452
16.

The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care.

Joore IK, Twisk DE, Vanrolleghem AM, de Ridder M, Geerlings SE, van Bergen JE, van den Broek IV.

BMC Fam Pract. 2016 Nov 17;17(1):161.

17.

Ethnic and regional differences in STI clinic use: a Dutch epidemiological study using aggregated STI clinic data combined with population numbers.

van Oeffelen AA, van den Broek IV, Doesburg M, Boogmans B, Götz HM, van Leeuwen-Voerman FA, van Veen MG, Woestenberg PJ, van Benthem BH, van Steenbergen JE.

Sex Transm Infect. 2017 Feb;93(1):46-51. doi: 10.1136/sextrans-2016-052558. Epub 2016 Jun 28.

PMID:
27606682
18.

Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women.

van der Weele P, van Logchem E, Wolffs P, van den Broek I, Feltkamp M, de Melker H, Meijer CJ, Boot H, King AJ.

J Clin Virol. 2016 Oct;83:6-11. doi: 10.1016/j.jcv.2016.07.020. Epub 2016 Aug 4.

PMID:
27522635
19.

Missed opportunities to offer HIV tests to high-risk groups during general practitioners' STI-related consultations: an observational study.

Joore IK, Reukers DF, Donker GA, van Sighem AI, Op de Coul EL, Prins JM, Geerlings SE, Barth RE, van Bergen JE, van den Broek IV.

BMJ Open. 2016 Jan 21;6(1):e009194. doi: 10.1136/bmjopen-2015-009194.

20.

Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping.

van den Broek I, Romijn FP, Nouta J, van der Laarse A, Drijfhout JW, Smit NP, van der Burgt YE, Cobbaert CM.

Clin Chem. 2016 Jan;62(1):188-97. doi: 10.1373/clinchem.2015.246702. Epub 2015 Nov 19.

21.

Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey.

van den Broek IV, Sfetcu O, van der Sande MA, Andersen B, Herrmann B, Ward H, Götz HM, Uusküla A, Woodhall SC, Redmond SM, Amato-Gauci AJ, Low N, van Bergen JE.

Eur J Public Health. 2016 Jun;26(3):382-8. doi: 10.1093/eurpub/ckv196. Epub 2015 Oct 24.

22.

Retesting young STI clinic visitors with urogenital Chlamydia trachomatis infection in the Netherlands; response to a text message reminder and reinfection rates: a prospective study with historical controls.

Kampman C, Koedijk F, Driessen-Hulshof H, Hautvast J, van den Broek I.

Sex Transm Infect. 2016 Mar;92(2):124-9. doi: 10.1136/sextrans-2015-052115. Epub 2015 Sep 24.

PMID:
26404946
23.

LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.

van den Broek I, van Dongen WD.

Bioanalysis. 2015;7(15):1943-58. doi: 10.4155/bio.15.113.

PMID:
26295992
24.

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.

Vriend HJ, Bogaards JA, van Bergen JE, Brink AA, van den Broek IV, Hoebe CJ, King AJ, van der Sande MA, Wolffs PF, de Melker HE; Medical Microbiological Laboratories and the CSI group.

Cancer Med. 2015 Oct;4(10):1589-98. doi: 10.1002/cam4.496. Epub 2015 Jul 21.

25.

Comparison of STI-related consultations among ethnic groups in the Netherlands: an epidemiologic study using electronic records from general practices.

Woestenberg PJ, van Oeffelen AA, Stirbu-Wagner I, van Benthem BH, van Bergen JE, van den Broek IV.

BMC Fam Pract. 2015 Jun 18;16:70. doi: 10.1186/s12875-015-0281-2.

26.

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.

WorldWide Antimalarial Resistance Network (WWARN) AS-AQ Study Group, Adjuik MA, Allan R, Anvikar AR, Ashley EA, Ba MS, Barennes H, Barnes KI, Bassat Q, Baudin E, Björkman A, Bompart F, Bonnet M, Borrmann S, Brasseur P, Bukirwa H, Checchi F, Cot M, Dahal P, D'Alessandro U, Deloron P, Desai M, Diap G, Djimde AA, Dorsey G, Doumbo OK, Espié E, Etard JF, Fanello CI, Faucher JF, Faye B, Flegg JA, Gaye O, Gething PW, González R, Grandesso F, Guerin PJ, Guthmann JP, Hamour S, Hasugian AR, Hay SI, Humphreys GS, Jullien V, Juma E, Kamya MR, Karema C, Kiechel JR, Kremsner PG, Krishna S, Lameyre V, Ibrahim LM, Lee SJ, Lell B, Mårtensson A, Massougbodji A, Menan H, Ménard D, Menéndez C, Meremikwu M, Moreira C, Nabasumba C, Nambozi M, Ndiaye JL, Nikiema F, Nsanzabana C, Ntoumi F, Ogutu BR, Olliaro P, Osorio L, Ouédraogo JB, Penali LK, Pene M, Pinoges L, Piola P, Price RN, Roper C, Rosenthal PJ, Rwagacondo CE, Same-Ekobo A, Schramm B, Seck A, Sharma B, Sibley CH, Sinou V, Sirima SB, Smith JJ, Smithuis F, Somé FA, Sow D, Staedke SG, Stepniewska K, Swarthout TD, Sylla K, Talisuna AO, Tarning J, Taylor WR, Temu EA, Thwing JI, Tjitra E, Tine RC, Tinto H, Vaillant MT, Valecha N, Van den Broek I, White NJ, Yeka A, Zongo I.

BMC Med. 2015 Mar 31;13:66. doi: 10.1186/s12916-015-0301-z.

27.

Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA-MALDI-TOF-MS workflow.

van den Broek I, Nouta J, Razavi M, Yip R, Bladergroen MR, Romijn FP, Smit NP, Drews O, Paape R, Suckau D, Deelder AM, van der Burgt YE, Pearson TW, Anderson NL, Cobbaert CM.

Methods. 2015 Jun 15;81:74-85. doi: 10.1016/j.ymeth.2015.03.001. Epub 2015 Mar 9.

PMID:
25766926
28.

Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands.

de Wit GA, Over EA, Schmid BV, van Bergen JE, van den Broek IV, van der Sande MA, Welte R, Op de Coul EL, Kretzschmar ME.

Sex Transm Infect. 2015 Sep;91(6):423-9. doi: 10.1136/sextrans-2014-051677. Epub 2015 Mar 10.

PMID:
25759475
29.

Urogenital Chlamydia trachomatis strain types, defined by high-resolution multilocus sequence typing, in relation to ethnicity and urogenital symptoms among a young screening population in Amsterdam, The Netherlands.

Versteeg B, Himschoot M, van den Broek IV, Bom RJ, Speksnijder AG, Schim van der Loeff MF, Bruisten SM.

Sex Transm Infect. 2015 Sep;91(6):415-22. doi: 10.1136/sextrans-2014-051790. Epub 2015 Feb 16.

PMID:
25688105
30.

Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis.

Redmond SM, Alexander-Kisslig K, Woodhall SC, van den Broek IV, van Bergen J, Ward H, Uusküla A, Herrmann B, Andersen B, Götz HM, Sfetcu O, Low N.

PLoS One. 2015 Jan 23;10(1):e0115753. doi: 10.1371/journal.pone.0115753. eCollection 2015. Review.

31.

Quantifying protein measurands by peptide measurements: where do errors arise?

van den Broek I, Romijn FP, Smit NP, van der Laarse A, Drijfhout JW, van der Burgt YE, Cobbaert CM.

J Proteome Res. 2015 Feb 6;14(2):928-42. doi: 10.1021/pr5011179. Epub 2015 Jan 6.

PMID:
25494833
32.

Metrological traceability in mass spectrometry-based targeted protein quantitation: a proof-of-principle study for serum apolipoproteins A-I and B100.

Smit NP, Romijn FP, van den Broek I, Drijfhout JW, Haex M, van der Laarse A, van der Burgt YE, Cobbaert CM.

J Proteomics. 2014 Sep 23;109:143-61. doi: 10.1016/j.jprot.2014.06.015. Epub 2014 Jun 25.

PMID:
24972322
33.

Chlamydia trachomatis Antibody Testing in Vaginal Mucosal Material versus Blood Samples of Women Attending a Fertility Clinic and an STI Clinic.

van den Broek IV, Land JA, van Bergen JE, Morré SA, van der Sande MA.

Obstet Gynecol Int. 2014;2014:601932. doi: 10.1155/2014/601932. Epub 2014 Mar 13.

34.

Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands in 1996 and in 2007: differential changes by gender and age.

van Aar F, de Moraes M, Morré SA, van Bergen JE, van der Klis FR, Land JA, van der Sande MA, van den Broek IV.

Sex Transm Infect. 2014 Aug;90(5):434-40. doi: 10.1136/sextrans-2013-051074. Epub 2014 Feb 28.

PMID:
24583966
35.

Consultations for sexually transmitted infections in the general practice in the Netherlands: an opportunity to improve STI/HIV testing.

Trienekens SC, van den Broek IV, Donker GA, van Bergen JE, van der Sande MA.

BMJ Open. 2013 Dec 30;3(12):e003687. doi: 10.1136/bmjopen-2013-003687.

36.

Current trends in mass spectrometry of peptides and proteins: Application to veterinary and sports-doping control.

van den Broek I, Blokland M, Nessen MA, Sterk S.

Mass Spectrom Rev. 2015 Nov-Dec;34(6):571-94. doi: 10.1002/mas.21419. Epub 2013 Dec 21. Review.

PMID:
24375671
37.

Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms.

Dukers-Muijrers NH, Speksnijder AG, Morré SA, Wolffs PF, van der Sande MA, Brink AA, van den Broek IV, Werner MI, Hoebe CJ.

PLoS One. 2013 Nov 20;8(11):e81236. doi: 10.1371/journal.pone.0081236. eCollection 2013.

38.

Use of Chlamydia trachomatis high-resolution typing: an extended case study to distinguish recurrent or persistent infection from new infection.

Götz HM, Bom RJ, Wolfers ME, Fennema J, van den Broek IV, Speksnijder AG, Bruisten SM.

Sex Transm Infect. 2014 Mar;90(2):155-60. doi: 10.1136/sextrans-2013-051218. Epub 2013 Nov 14.

PMID:
24234071
39.

Evaluation of interspecimen trypsin digestion efficiency prior to multiple reaction monitoring-based absolute protein quantification with native protein calibrators.

van den Broek I, Smit NP, Romijn FP, van der Laarse A, Deelder AM, van der Burgt YE, Cobbaert CM.

J Proteome Res. 2013 Dec 6;12(12):5760-74. doi: 10.1021/pr400763d. Epub 2013 Nov 13.

PMID:
24168082
40.

A qualitative participatory study to identify experiences of coronary heart disease patients to support the development of online self-management services.

Vosbergen S, Janzen J, Stappers PJ, van Zwieten MC, Lacroix J, Idema K, van den Broek I, Kemps HM, Kraaijenhagen RA, Peek N.

Int J Med Inform. 2013 Dec;82(12):1183-94. doi: 10.1016/j.ijmedinf.2013.09.001. Epub 2013 Sep 17.

PMID:
24113277
41.

[Risks associated with phytoestrogen dietary supplementation and adjuvant hormonal therapy for breast cancer].

van Duursen MB, van den Broek I, de Jong PC, van den Berg M.

Ned Tijdschr Geneeskd. 2013;157(40):A6069. Dutch.

PMID:
24004923
42.

[Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].

Koedijk FD, van den Broek I, Stirbu-Wagner I, van Bergen JE.

Ned Tijdschr Geneeskd. 2013;157(24):A5642. Review. Dutch.

PMID:
23759175
43.

Retesting for genital Chlamydia trachomatis among visitors of a sexually transmitted infections clinic: randomized intervention trial of home- versus clinic-based recall.

Götz HM, Wolfers ME, Luijendijk A, van den Broek IV.

BMC Infect Dis. 2013 May 24;13:239. doi: 10.1186/1471-2334-13-239.

44.

Bioanalytical LC-MS/MS of protein-based biopharmaceuticals.

van den Broek I, Niessen WM, van Dongen WD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jun 15;929:161-79. doi: 10.1016/j.jchromb.2013.04.030. Epub 2013 Apr 26. Review.

PMID:
23685427
45.

Twenty-two years of HIV-related consultations in Dutch general practice: a dynamic cohort study.

Donker G, Dorsman S, Spreeuwenberg P, van den Broek I, van Bergen J.

BMJ Open. 2013 Apr 26;3(4). pii: e001834. doi: 10.1136/bmjopen-2012-001834. Print 2013.

46.

Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates.

Schmid BV, Over EA, van den Broek IV, Op de Coul EL, van Bergen JE, Fennema JS, Götz HM, Hoebe CJ, de Wit GA, van der Sande MA, Kretzschmar ME.

PLoS One. 2013;8(3):e58674. doi: 10.1371/journal.pone.0058674. Epub 2013 Mar 20.

47.

Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.

van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Koekenbier RH, Kretzschmar M, Over EA, Schmid BV, Pars LL, van Ravesteijn SM, van der Sande MA, de Wit GA, Low N, Op de Coul EL.

BMJ. 2012 Jul 5;345:e4316. doi: 10.1136/bmj.e4316.

48.

High yield of reinfections by home-based automatic rescreening of Chlamydia positives in a large-scale register-based screening programme and determinants of repeat infections.

Götz HM, van den Broek IV, Hoebe CJ, Brouwers EE, Pars LL, Fennema JS, Koekenbier RH, van Ravesteijn S, Op de Coul EL, van Bergen J.

Sex Transm Infect. 2013 Feb;89(1):63-9. doi: 10.1136/sextrans-2011-050455. Epub 2012 Jun 23.

PMID:
22728910
49.

Keeping participants on board: increasing uptake by automated respondent reminders in an Internet-based chlamydia screening in the Netherlands.

Dokkum NF, Koekenbier RH, van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Pars LL, van Ravesteijn SM, Op de Coul EL.

BMC Public Health. 2012 Mar 9;12:176. doi: 10.1186/1471-2458-12-176.

50.

Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity.

Op de Coul EL, Götz HM, van Bergen JE, Fennema JS, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van der Sande MA, van den Broek IV.

Sex Transm Dis. 2012 Feb;39(2):97-103. doi: 10.1097/OLQ.0b013e3182383097.

PMID:
22249297

Supplemental Content

Loading ...
Support Center